UTI Focused Fund

Direct · Growth

AI Summary

Performance

UTI Focused Fund has consistently outperformed the NIFTY 50 across all measured periods, with a 3Y fund CAGR of 8.18% versus the benchmark's 4.15% and a 1Y CAGR of -6.03% versus -11.35%. However, its SIP XIRR trails the category average at every horizon — 14.19% vs 15.85% over 3Y and 9.86% vs 15.55% over 5Y. Positive alpha across all windows (6.25% at 1Y, 3.92% at 3Y) confirms genuine benchmark outperformance despite lagging peers.

Risk

The fund displays defensive characteristics with a beta below 1 (0.91 at 5Y) and downside capture of just 87.92% at 5Y, meaning it loses less than the benchmark in falling markets. It has experienced 2 drawdown events exceeding 10%, with the maximum drawdown lasting 155 days. Calmar ratios of 0.81 at 3Y and 0.50 at 5Y indicate moderate risk-adjusted efficiency relative to drawdown depth.

Portfolio

As a focused fund, the portfolio holds a concentrated set of roughly 20-30 stocks, which increases single-stock and sector concentration risk compared to diversified funds. This concentrated structure has enabled the fund's consistent alpha generation against the NIFTY 50. Investors should note that concentration cuts both ways, amplifying losses when specific holdings underperform.

Category Positioning

While the fund beats its benchmark decisively, it underperforms the focused fund category on SIP XIRR at all horizons, trailing by 1.66% at 3Y and 5.69% at 5Y. Calendar year returns show mixed consistency — a strong 30.41% in 2023 but only 0.23% in 2022 and -8.09% in 2026. The fund's edge is benchmark-relative rather than peer-relative.

Investor Suitability

This fund suits investors seeking benchmark-beating returns with below-market downside risk, ideally with a 5-7 year horizon to ride out drawdowns like the 155-day recovery period. It is appropriate for moderate risk tolerance given its sub-1 beta and strong downside capture. Investors prioritizing category-leading SIP returns may find better alternatives among focused fund peers.

  • Positive alpha across all periods from 1Y to 15Y, including 6.25% at 1Y and 3.92% at 3Y versus the NIFTY 50
  • Strong downside protection with downside capture of 87.92% at 5Y and beta of 0.91
  • Low expense ratio of 0.65% for a focused equity fund in the Direct Growth option

  • SIP XIRR trails the category average at every horizon, including 9.86% vs 15.55% over 5Y
  • Two drawdown events exceeding 10% with the maximum drawdown taking 155 days, and weak 2026 return of -8.09%

Generated on 14-10-2026, 4:14 AM. Verify before investing.

₹15.84
19 Oct 2026
NAV
15.7%
3Y CAGR
9.5%
5Y CAGR
12.0%
Weighted CAGR
?
3.40
Sharpe
-19.3%
Max Drawdown
?
0.65%
TER

If you invested ₹1,00,000 every month via SIP, here's how this fund has historically performed across different time horizons.

Duration Invested Median Value XIRR Min XIRR Max XIRR
1 Year ₹12.00 L ₹12.57 L 13.9% -22.4% 54.9%
3 Years ₹36.00 L ₹44.33 L 14.5% -0.4% 32.8%
5 Years ₹60.00 L ₹77.00 L 10.0% 7.0% 11.6%

SIP returns vs benchmark & category

Annualised SIP return (XIRR) over each rolling horizon — like-for-like, not lump-sum.

Duration Fund SIP XIRR NIFTY 50 Category avg Fund edge
1 Year 13.9% 14.3% 11.2% -0.4%
3 Years 14.5% 11.0% 15.8% +3.5%
5 Years 10.0% 10.4% 15.5% -0.4%

Duration Mean Median Min Max Sharpe Sortino % Positive Cat. Mean Cat. Median
1 Year 13.5% 8.3% -8.4% 45.6% 0.49 1.65 84% — —
3 Years 15.7% 16.0% 8.2% 22.6% 3.12 — 100% — —
5 Years 9.5% 9.3% 8.1% 11.1% 3.40 — 100% — —

-19.3%
Max Drawdown
5 mo
Drawdown Duration
Not recovered
Recovery Time
-5.7%
Avg Drawdown

Calmar Ratio by Duration

0.70
1Y
0.81
3Y
0.49
5Y

Compared against NIFTY 50

Duration Alpha Beta Upside Capture Downside Capture Fund CAGR Bench CAGR
1 Year +5.84 1.05 104.8% 98.0% -6.4% -11.4%
3 Years +3.55 0.95 98.1% 93.2% 8.9% 5.3%
5 Years +3.72 0.91 93.2% 88.0% 8.3% 4.4%
7 Years +1.95 0.90 91.9% 87.5% 6.7% 4.6%
10 Years +1.15 0.90 91.9% 87.5% 4.7% 3.2%
12 Years +0.84 0.90 91.9% 87.5% 3.9% 2.7%
15 Years +0.55 0.90 91.9% 87.5% 3.1% 2.1%